Zimmer Spine’s FDA clearance for its Optio-C Anterior Cervical Plate

Zimmer Spine received 510(k) clearance from the U.S. Food and Drug Administration for its Optio-C Anterior Cervical Plate.

Advertisement

The plate is intended for use with structural allograft/autograft as a stand-alone cervical system for cervical fusion procedures. The device is secured by an anti-migration system that is designed to maintain no profile.

 

Zimmer Spine focuses on developing comprehensive surgical solutions, training and clinical support that advance and support spine surgeons.

More articles on devices:

LDR, Wright Medical, NuVasive & more — 15 key notes
Halifax Biomedical names Allan Pozdol vice president of sales
SpineFrontier to manufacture an intervertebral body fusion device with Invibio’s PEEK-OPTIMA HA Enhanced

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.